Literature DB >> 8430269

Assessment of disease severity and activity in inflammatory bowel disease.

J Kjeldsen1, O B Schaffalitzky de Muckadell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8430269     DOI： 10.3109/00365529309096037

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN： 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  14 in total

1.  Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.

Authors:  R K Linskens; A A van Bodegraven; M Schoorl; H A Tuynman; P Bartels
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 2.  Evaluation of new therapies for inflammatory bowel disease.

Authors:  E Carty; D S Rampton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

Review 3.  Technetium leukocyte imaging in inflammatory bowel disease.

Authors:  M Charron
Journal:  Curr Gastroenterol Rep       Date:  1999-06

4.  Expression of E-selectin, sialyl Lewis X, and macrophage inflammatory protein-1alpha by colonic epithelial cells in ulcerative colitis.

Authors:  B Vainer; O H Nielsen; T Horn
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

5.  Resistance index in mural arteries of thickened bowel wall: predictive value for Crohn disease activity assessment in pediatric patients.

Authors:  Ivica Sjekavica; Vinka Barbarić-Babić; Vice Šunjara; Marko Kralik; Irena Senečić-Čala; Margareta Dujšin; Ranka Stern-Padovan
Journal:  Wien Klin Wochenschr       Date:  2013-04-13       Impact factor: 1.704

6.  Assessment of Crohn's disease activity by doppler ultrasound of superior mesenteric artery and mural arteries in thickened bowel wall: cross-sectional study.

Authors:  Ivica Sjekavica; Vinka Barbarić-Babić; Zeljko Krznarić; Melita Molnar; Silvija Cuković-Cavka; Ranka Stern-Padovan
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

7.  Increased leucocyte adhesiveness/aggregation is a most useful indicator of disease activity in patients with inflammatory bowel disease.

Authors:  N Arber; S Berliner; A Hallak; Y Bujanover; I Dotan; E Liberman; M Santo; M Moshkowitz; J Ratan; G Dotan
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

8.  Carbonic anhydrase I reduction in colonic mucosa of patients with active ulcerative colitis.

Authors:  R Fonti; G Latella; R Caprilli; G Frieri; A Marcheggiano; Y Sambuy
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

9.  Questions on life satisfaction (FLZM) in inflammatory bowel disease.

Authors:  K-H Janke; A Raible; M Bauer; P Clemens; C Meisner; W Häuser; U Steder-Neukamm; G Henrich; P Herschbach; M Gregor; B Klump
Journal:  Int J Colorectal Dis       Date:  2003-10-28       Impact factor: 2.571

10.  Changes of blood flow volume in the superior mesenteric artery and brachial artery with abdominal thermal stimulation.

Authors:  Shin Takayama; Takashi Seki; Masashi Watanabe; Shigeru Takashima; Norihiro Sugita; Satoshi Konno; Takashi Takeda; Hiroyuki Arai; Tomoyuki Yambe; Nobuo Yaegashi; Makoto Yoshizawa; Shigenao Maruyama; Shin-Ichi Nitta
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-13       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.